Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18796784 | Anisotropic Conductive Electrical Connection From A Conductive Pathway Through A Ceramic Casing To A Circuit Board Electronic Component Housed Inside The Casing | August 2024 | April 2025 | Allow | 8 | 1 | 0 | No | No |
| 18592095 | IMPLANTABLE MEDICAL DEVICES AND RELATED METHODS THEREOF | February 2024 | August 2024 | Allow | 5 | 1 | 0 | Yes | No |
| 18259498 | Health Monitoring and Management System Using Ectopic Beats as Early Cardiac Health Marker | June 2023 | February 2026 | Abandon | 32 | 1 | 0 | No | No |
| 18256914 | CIRCULATORY SUPPORT DEVICES AND METHODS | June 2023 | February 2026 | Abandon | 32 | 1 | 0 | No | No |
| 18196688 | STRAIN RELIEF SYSTEMS FOR ACTIVE IMPLANTABLE MEDICAL DEVICES | May 2023 | August 2025 | Allow | 27 | 1 | 0 | No | No |
| 18297540 | TRANSMANDIBULAR STERILE CONDUIT | April 2023 | February 2026 | Abandon | 34 | 1 | 0 | No | No |
| 18107839 | WEARABLE SENSOR-BASED DEVICE FOR PREDICTING, MONITORING, AND CONTROLLING EPILEPSY AND METHODS THEREOF | February 2023 | January 2026 | Abandon | 35 | 1 | 0 | No | No |
| 18165872 | Glucose-Based Modulation of Electrical Stimulation To Enable Weight Loss | February 2023 | November 2023 | Allow | 9 | 1 | 0 | No | No |
| 18160963 | Versatile Modular Heart Pump for Non-Blood Contacting Ventricular Function Augmentation | January 2023 | November 2023 | Allow | 9 | 1 | 0 | No | No |
| 18153977 | Wearable Heartbeat and Breathing Waveform Continuous Monitoring System | January 2023 | February 2026 | Abandon | 37 | 1 | 1 | No | No |
| 18045310 | SYSTEM FOR PROGNOSTICATING PATIENT OUTCOMES AND METHODS OF USING THE SAME | October 2022 | October 2025 | Abandon | 37 | 1 | 0 | No | No |
| 17914908 | LIVING BODY SENSOR | September 2022 | March 2026 | Allow | 42 | 1 | 0 | No | No |
| 17897284 | DEVICES AND METHODS FOR TREATING CRANIOFACIAL PAIN | August 2022 | August 2025 | Allow | 35 | 1 | 0 | No | No |
| 17659704 | METHODS TO PREVENT STRESS REMODELING OF ATRIAL TISSUE | April 2022 | January 2026 | Abandon | 45 | 2 | 0 | No | No |
| 17765931 | MEDICAL SYSTEM COMPRISING AN IMPLANTED INTERNAL UNIT, AN EXTERNAL UNIT, AND A METHOD OF INITIATING OPERATION OF EXTERNAL UNIT | April 2022 | December 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17711539 | HEARING DEVICE USING A COCHLEAR IMPLANT SYSTEM AND CONTROL METHOD THEREOF | April 2022 | January 2026 | Abandon | 45 | 1 | 0 | Yes | No |
| 17673376 | CANNULA ASSEMBLY | February 2022 | April 2025 | Allow | 38 | 0 | 0 | No | No |
| 17590972 | SEALING DEVICE AND DELIVERY SYSTEM | February 2022 | December 2025 | Abandon | 46 | 1 | 0 | No | No |
| 17554930 | DEVICE AND METHOD TO SELECTIVELY AND REVERSIBLY MODULATE A NERVOUS SYSTEM STRUCTURE TO INHIBIT PAIN | December 2021 | March 2025 | Allow | 39 | 1 | 0 | No | No |
| 17525830 | SUBSURFACE ELECTRODES FOR ELECTRIC FIELD SHAPING WITH PROTRUDING SUPPORTING STRUCTURES | November 2021 | August 2022 | Allow | 9 | 1 | 0 | Yes | No |
| 17521521 | METHOD AND APPARATUS FOR MULTl MODAL ELECTRICAL MODULATION OF PAIN USING COMPOSITE ELECTROMAGNETIC FIELDS | November 2021 | August 2025 | Allow | 45 | 1 | 0 | Yes | No |
| 17501732 | DEVICES AND METHODS FOR SENSING PHYSIOLOGICAL SIGNALS DURING STIMULATION THERAPY | October 2021 | January 2025 | Allow | 39 | 0 | 0 | No | No |
| 17603068 | SYSTEM FOR PROGNOSTICATING PATIENT OUTCOMES AND METHODS OF USING THE SAME | October 2021 | May 2022 | Allow | 7 | 1 | 0 | No | No |
| 17484186 | NEUROMODULATION CATHETERS HAVING JACKETED NEUROMODULATION ELEMENTS AND RELATED DEVICES, SYSTEMS, AND METHODS | September 2021 | August 2025 | Allow | 46 | 2 | 0 | Yes | No |
| 17448556 | SENSOR DEVICE | September 2021 | July 2025 | Allow | 46 | 1 | 0 | Yes | No |
| 17447327 | Electrical Stimulation-Based Weight Management System | September 2021 | November 2025 | Abandon | 50 | 1 | 0 | No | No |
| 17397192 | SYSTEMS AND METHODS FOR CONTROLLING LEVELS OF PERCEIVED INTENSITY OF A SENSORY STIMULUS | August 2021 | June 2025 | Allow | 46 | 1 | 0 | No | No |
| 17383867 | ELECTRODE ARRAYS AND COCHLEAR IMPLANTS INCLUDING THE SAME | July 2021 | June 2025 | Allow | 46 | 2 | 0 | No | No |
| 17375700 | HIDDEN COCHLEAR IMPLANT SYSTEM | July 2021 | January 2022 | Allow | 6 | 1 | 1 | No | No |
| 17362346 | OPERATING METHOD OF 3D PHYSIOLOGICAL DETECTION SYSTEM AND HOST | June 2021 | October 2024 | Allow | 40 | 0 | 0 | No | No |
| 17362297 | 3D PHYSIOLOGICAL DETECTION SYSTEM AND HOST DISPLAYING 3D ENERGY DISTRIBUTION | June 2021 | September 2024 | Allow | 39 | 1 | 0 | No | No |
| 17346733 | System and Method for Electrically Ablating Tissue of a Patient | June 2021 | January 2024 | Allow | 31 | 1 | 0 | No | No |
| 17343375 | METHOD OF POLARIZATION CONTROL OF EVANESCENT WAVES FOR TREATING TUMORS | June 2021 | March 2025 | Allow | 45 | 2 | 0 | No | No |
| 17339380 | HIDDEN COCHLEAR IMPLANT SYSTEM | June 2021 | January 2025 | Allow | 43 | 3 | 0 | No | No |
| 17316366 | ASSOCIATING THERAPY ADJUSTMENTS WITH POSTURE STATES USING A STABILITY TIMER | May 2021 | April 2025 | Allow | 47 | 1 | 0 | Yes | No |
| 17301923 | LATENCY-BASED ADAPTATION OF ANTI-TACHYARRHYTHMIA PACING THERAPY | April 2021 | January 2025 | Allow | 44 | 1 | 0 | Yes | No |
| 17214799 | HAND-MANIPULATED INPUT DEVICE WITH HALL EFFECT SENSOR FOR ROBOTIC SYSTEM | March 2021 | March 2025 | Allow | 48 | 1 | 0 | No | No |
| 17205614 | Signal Conducting Device for Concurrent Power and Data Transfer To and From Un-Wired Sensors Attached to a Medical Device | March 2021 | September 2021 | Allow | 6 | 1 | 0 | Yes | No |
| 17197058 | METHOD AND APPARATUS FOR SUPPLYING ENERGY TO A MEDICAL DEVICE | March 2021 | December 2024 | Allow | 45 | 2 | 0 | No | No |
| 17171418 | Electrical Connection For A Hermetic Terminal For An Active Implantable Medical Device Utilizing A Ferrule Pocket | February 2021 | March 2023 | Allow | 25 | 1 | 0 | No | No |
| 17165500 | Electrical Connection For An AIMD Utilizing An Anisotropic Conductive Layer | February 2021 | April 2024 | Allow | 38 | 1 | 0 | No | No |
| 17154627 | METHOD AND APPARATUS FOR MULTl MODAL ELECTRICAL MODULATION OF PAIN USING COMPOSITE ELECTROMAGNETIC FIELDS | January 2021 | July 2021 | Allow | 5 | 1 | 0 | Yes | No |
| 17150304 | INTRAORAL PHOTOTHERAPY DEVICE | January 2021 | March 2022 | Allow | 14 | 1 | 1 | Yes | No |
| 17112267 | CATHETER FOR MONITORING UTERINE CONTRACTION PRESSURE | December 2020 | November 2024 | Allow | 48 | 1 | 0 | No | No |
| 17096433 | SYSTEM AND METHOD OF MONITORING FOR AND REPORTING ON PATIENT-MADE STIMULATION THERAPY PROGRAMMING CHANGES | November 2020 | March 2025 | Allow | 52 | 1 | 0 | No | No |
| 17092980 | DEVICE AND METHOD TO SELECTIVELY AND REVERSIBLY MODULATE A NERVOUS SYSTEM STRUCTURE TO INHIBIT PAIN | November 2020 | August 2021 | Allow | 9 | 2 | 0 | No | No |
| 17032118 | CATHETER FOR MONITORING INTRAUTERINE PRESSURE TO PROTECT THE FALLOPIAN TUBES | September 2020 | March 2025 | Abandon | 53 | 1 | 0 | No | No |
| 17028739 | Mobility-Enhancing Blood Pump System | September 2020 | September 2024 | Allow | 48 | 1 | 0 | Yes | No |
| 17025444 | CATHETER FOR MONITORING UTERINE CONTRACTION PRESSURE | September 2020 | September 2024 | Allow | 48 | 1 | 0 | No | No |
| 17010702 | IMPLANTABLE NEURO-STIMULATION DEVICE | September 2020 | August 2024 | Abandon | 47 | 1 | 0 | No | No |
| 17008873 | ROTOR FOR A FLUID PUMP AND METHOD AND MOLD FOR THE PRODUCTION THEREOF | September 2020 | August 2025 | Allow | 59 | 2 | 0 | No | No |
| 17009224 | METHOD FOR PUMP START IN A FULLY IMPLANTED LVAD SYSTEM WHEN MULTIPLE POWER SOURCES MAY BE PRESENT | September 2020 | January 2025 | Allow | 52 | 1 | 0 | No | No |
| 17008523 | METHODS, DEVICES, AND SYSTEMS FOR COMMUNICATING WITH AN IMPLANTABLE MEDICAL DEVICE OF A LAST FAR FIELD COMMUNICATION SESSION DURING A SUBSEQUENT FAR FIELD COMMUNICATION SESSION WHILE USING A SAME SESSION KEY | August 2020 | October 2023 | Allow | 37 | 1 | 0 | No | No |
| 16910832 | STATE-BASED ATRIAL EVENT DETECTION | June 2020 | August 2024 | Allow | 50 | 1 | 0 | No | No |
| 16868188 | METHOD AND APPARATUS FOR MULTl MODAL OR MULTIPLEXED ELECTRICAL MODULATION OF PAIN USING COMPOSITE ELECTROMAGNETIC FIELDS | May 2020 | October 2023 | Allow | 42 | 2 | 1 | No | No |
| 16864218 | Oral Care Implement with Conductive Protrusions | May 2020 | May 2024 | Allow | 48 | 1 | 0 | No | No |
| 16849045 | LOCALIZATION SYSTEM AND METHOD USEFUL IN THE ACQUISITION AND ANALYSIS OF CARDIAC INFORMATION | April 2020 | March 2024 | Allow | 47 | 0 | 0 | No | No |
| 16840968 | FULLY IMPLANTABLE MODULAR COCHLEAR IMPLANT SYSTEM | April 2020 | September 2024 | Allow | 54 | 1 | 0 | No | No |
| 16827171 | HERMETICALLY SEALED FILTERED FEEDTHROUGH HAVING PLATIUM SEALED DIRECTLY TO THE INSULATOR IN A VIA HOLE | March 2020 | March 2021 | Allow | 12 | 1 | 0 | Yes | No |
| 16825678 | IMPLANTABLE SYSTEM FOR STIMULATING A HUMAN HEART OR AN ANIMAL HEART | March 2020 | February 2023 | Allow | 34 | 1 | 0 | No | No |
| 16820388 | CONTEXTUALLY AWARE FETAL SENSING IN TRANSABDOMINAL FETAL PULSE OXIMETRY | March 2020 | April 2024 | Allow | 49 | 1 | 0 | No | No |
| 16814220 | METHODS AND DEVICES FOR SELECTIVE DISRUPTION OF VISCERAL FAT BY CONTROLLED COOLING | March 2020 | August 2025 | Allow | 60 | 4 | 0 | No | No |
| 16639556 | APPARATUS AND METHOD FOR DECODING AND RESTORING COGNITIVE FUNCTIONS | February 2020 | March 2023 | Allow | 37 | 1 | 1 | No | No |
| 16791438 | IMPLANTABLE MEDICAL APPARATUS WITH INTERCONNECTED ELECTRODES | February 2020 | August 2024 | Abandon | 54 | 1 | 0 | No | No |
| 16787135 | SYSTEM AND METHOD FOR REAL-TIME HEARTBEAT EVENTS DETECTION USING LOW-POWER MOTION SENSOR | February 2020 | April 2024 | Allow | 50 | 1 | 0 | Yes | No |
| 16785916 | SUPRAVENTRICULAR TACHYARRHYTHMIA DISCRIMINATION | February 2020 | January 2024 | Allow | 47 | 1 | 0 | No | No |
| 16785744 | SYSTEMS AND METHODS FOR CLASSIFYING ECG DATA | February 2020 | November 2023 | Allow | 45 | 1 | 0 | No | No |
| 16779794 | Energy transfer control adapted to a medical device system | February 2020 | September 2023 | Allow | 43 | 1 | 0 | No | No |
| 17300305 | METHOD AND APPARATUS FOR MULTl MODAL ELECTRICAL MODULATION OF PAIN USING COMPOSITE ELECTROMAGNETIC FIELDS | January 2020 | February 2023 | Allow | 37 | 1 | 0 | No | No |
| 16748161 | SYSTEMS AND METHODS FOR CLOSED-LOOP DETERMINATION OF STIMULATION PARAMETER SETTINGS FOR AN ELECTRICAL SIMULATION SYSTEM | January 2020 | April 2023 | Allow | 39 | 1 | 0 | No | No |
| 16734859 | APPARATUS AND METHOD FOR SELF-GUIDED ABLATION | January 2020 | February 2022 | Abandon | 26 | 1 | 0 | No | No |
| 16732446 | SYSTEMS, DEVICES, AND METHODS FOR PROVIDING ELECTROTHERAPY | January 2020 | May 2023 | Allow | 40 | 1 | 0 | No | No |
| 16721823 | Subsurface electrodes for electric field shaping with protruding supporting structures | December 2019 | August 2021 | Allow | 20 | 1 | 0 | No | No |
| 16710928 | Cardiac Arrhythmia Report | December 2019 | February 2022 | Allow | 26 | 0 | 0 | No | No |
| 16696565 | DETERMINING RELIABILITY FOR ECG DATA USING SIGNAL-TO-NOISE RATIO | November 2019 | April 2022 | Allow | 29 | 2 | 0 | No | No |
| 16694990 | Systems and Methods for Using A Transcutaneous Electrical Stimulation Device to Deliver Titrated Therapy | November 2019 | March 2023 | Allow | 39 | 1 | 0 | No | No |
| 16691384 | STRAIN RELIEF SYSTEMS FOR ACTIVE IMPLANTABLE MEDICAL DEVICES | November 2019 | February 2023 | Allow | 39 | 1 | 0 | No | No |
| 16676679 | WEARABLE CARDIOVERTER DEFIBRILLATOR (WCD) SYSTEM USING SENSOR MODULES WITH REASSURANCE CODE FOR CONFIRMATION BEFORE SHOCK | November 2019 | January 2023 | Allow | 39 | 2 | 0 | No | No |
| 16676090 | DEVICE AND METHOD TO SELECTIVELY AND REVERSIBLY MODULATE A NERVOUS SYSTEM STRUCTURE TO INHIBIT PAIN | November 2019 | August 2020 | Allow | 9 | 1 | 0 | No | No |
| 16676202 | DEVICE AND METHOD TO SELECTIVELY AND REVERSIBLY MODULATE A NERVOUS SYSTEM STRUCTURE TO INHIBIT PAIN | November 2019 | May 2022 | Allow | 30 | 2 | 1 | Yes | No |
| 16659261 | HIS-BUNDLE OR BUNDLE BRANCH PACING CAPTURE VERIFICATION | October 2019 | March 2023 | Allow | 40 | 1 | 0 | No | No |
| 16655627 | IMPLANTABLE MEDICAL DEVICES, SYSTEMS, AND METHODS FOR SELECTION OF OPTIMAL DIAPHRAGMATIC STIMULATION PARAMETERS TO AFFECT PRESSURES WITHIN THE INTRATHORACIC CAVITY | October 2019 | April 2022 | Allow | 30 | 1 | 0 | No | No |
| 16654598 | IMPLANTABLE MEDICAL DEVICE AND METHOD OF PROVIDING WIRE CONNECTIONS FOR IT | October 2019 | July 2022 | Allow | 33 | 1 | 0 | No | No |
| 16601995 | WRIST WORN CARBON MONOXIDE DETECTOR | October 2019 | April 2020 | Allow | 6 | 1 | 0 | No | No |
| 16599102 | APPARATUS AND METHODS FOR MAKING COCHLEAR IMPLANT ELECTRODE ARRAYS | October 2019 | July 2022 | Allow | 33 | 1 | 0 | No | No |
| 16604383 | TOOLLESS LEAD CONNECTOR ASSEMBLY | October 2019 | January 2023 | Allow | 40 | 2 | 0 | Yes | No |
| 16597084 | IMPLANTABLE BLOOD PUMP ASSEMBLY INCLUDING OUTFLOW GRAFT FIXATION CLIP | October 2019 | July 2022 | Allow | 33 | 1 | 0 | No | No |
| 16593517 | ELECTRODE ASSEMBLIES, METHODS, AND COMPONENTS THEREOF FOR IMPLANTABLE MEDICAL ELECTRICAL LEADS | October 2019 | June 2022 | Allow | 32 | 2 | 0 | No | No |
| 16592963 | DEVICES AND METHODS FOR TREATING CRANIOFACIAL PAIN | October 2019 | April 2022 | Allow | 31 | 1 | 0 | No | No |
| 16590661 | DEVICES AND METHODS FOR SENSING PHYSIOLOGICAL SIGNALS DURING STIMULATION THERAPY | October 2019 | June 2021 | Allow | 21 | 1 | 0 | No | No |
| 16589017 | SYSTEMS AND METHODS FOR DETERMINING ENGAGEMENT OF A PORTABLE DEVICE | September 2019 | April 2022 | Allow | 30 | 1 | 0 | No | No |
| 16588262 | Wearable Cardiac Defibrillator System Authenticating Person Actuating Cancel Switch | September 2019 | June 2023 | Allow | 44 | 3 | 0 | No | No |
| 16578557 | Polarity Reversing Lead | September 2019 | May 2022 | Abandon | 32 | 1 | 0 | Yes | No |
| 16577565 | IMPLANTABLE VENTRICULAR ASSIST DEVICES AND METHODS | September 2019 | October 2023 | Allow | 48 | 3 | 1 | Yes | No |
| 16492539 | CARDIAC ASSIST DEVICE WITH INTEGRALLY TEXTURED MEMBRANE | September 2019 | April 2024 | Abandon | 55 | 4 | 0 | Yes | No |
| 16484922 | BRAIN-MACHINE INTERFACE SYSTEM CAPABLE OF CHANGING AMOUNT OF COMMUNICATION DATA FROM INTERNAL DEVICE, AND CONTROL METHOD THEREFOR | August 2019 | June 2023 | Allow | 46 | 1 | 0 | No | No |
| 16523716 | HEARING DEVICE USING A COCHLEAR IMPLANT SYSTEM AND CONTROL METHOD THEREOF | July 2019 | October 2021 | Allow | 27 | 1 | 0 | No | No |
| 16522234 | SEALING DEVICE AND DELIVERY SYSTEM | July 2019 | October 2021 | Allow | 27 | 1 | 0 | No | No |
| 16518697 | Nerve Stimulation System | July 2019 | March 2021 | Allow | 20 | 1 | 0 | No | No |
| 16508837 | ELECTRODE DESIGNS IN IMPLANTABLE DEFIBRILLATOR SYSTEMS | July 2019 | August 2021 | Allow | 25 | 1 | 0 | No | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner WEHRHEIM, LINDSEY GAIL.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 25.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner WEHRHEIM, LINDSEY GAIL works in Art Unit 3799 and has examined 169 patent applications in our dataset. With an allowance rate of 91.7%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 33 months.
Examiner WEHRHEIM, LINDSEY GAIL's allowance rate of 91.7% places them in the 77% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by WEHRHEIM, LINDSEY GAIL receive 1.51 office actions before reaching final disposition. This places the examiner in the 27% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by WEHRHEIM, LINDSEY GAIL is 33 months. This places the examiner in the 49% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +4.5% benefit to allowance rate for applications examined by WEHRHEIM, LINDSEY GAIL. This interview benefit is in the 28% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.
When applicants file an RCE with this examiner, 29.8% of applications are subsequently allowed. This success rate is in the 57% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.
This examiner enters after-final amendments leading to allowance in 64.3% of cases where such amendments are filed. This entry rate is in the 88% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 100% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.
This examiner withdraws rejections or reopens prosecution in 75.0% of appeals filed. This is in the 67% percentile among all examiners. Of these withdrawals, 33.3% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 52.9% are granted (fully or in part). This grant rate is in the 53% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 49% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 52% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.